• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胱氨酸结石患者与非胱氨酸结石患者的健康相关生活质量(HRQoL)比较。

Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers.

作者信息

Modersitzki Frank, Pizzi Laura, Grasso Michael, Goldfarb David S

机构信息

Kidney Stone Prevention Programs, Nephrology Section/111G, DVAMC, New York Harbor VA Medical Center and NYU School of Medicine, 423 E. 23 St., New York, NY, 10010, USA.

出版信息

Urolithiasis. 2014 Feb;42(1):53-60. doi: 10.1007/s00240-013-0621-4. Epub 2013 Nov 20.

DOI:10.1007/s00240-013-0621-4
PMID:24253538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4514515/
Abstract

Cystinuria is a genetic cause of recurrent kidney stones which may be more recurrent and larger than more common non-cystine stones. They may have a greater impact on health-related quality of life (HRQoL). We measured this impact by surveying HRQoL in patients with stones, comparing non-cystine stone formers (NCSF) to cystine stone formers (CYSF) and both groups to normative values of the US population. We used SF-36v2 via an internet instrument. CYSF patients were recruited via cystinuria-related websites, two patient advocacy groups, and an active endourology practice. NCSF patients were recruited from the same practice and by email. Total n surveyed with scorable data: 214 CYSF and 81 NCSF. The participants included 128 men and 161 women. The group of CYSF were significantly younger (39 vs. 54 years) and suffered longer from kidney stones (255 vs. 136 months). CYSF patients had significantly more episodes of stones than NCSF patients in the last year (N = 108 CYSF, N = 20 NCSF). More frequent stones in the last year and mental comorbidities most often predicted worse scores in the individual HRQoL domains. However, cystine stone composition was a significant predictor of worse scores only for role emotional. Better scores in all SF-36 domains were associated with greater time since the last kidney stone event. Although kidney stones are often transient, kidney stone formers, regardless of stone composition, have a worse HRQoL than the standard US population, which has a normative score of 50, such as general health (41.2 ± 12.8), bodily pain (46.5 ± 11.8) and mental health (45.1 ± 12.6). CYSF are more frequent and severe stone formers compared with NCSF with a resulting greater, direct impact on the HRQoL of CYSF patients. Whether preventive strategies for cystinuria are being properly utilized by practitioners, and which strategies are most effective, should be established.

摘要

胱氨酸尿症是复发性肾结石的一个遗传病因,与更常见的非胱氨酸结石相比,其复发可能更频繁且结石更大。它们可能对健康相关生活质量(HRQoL)产生更大影响。我们通过调查结石患者的HRQoL来衡量这种影响,将非胱氨酸结石形成者(NCSF)与胱氨酸结石形成者(CYSF)进行比较,并将两组与美国人群的标准值进行比较。我们通过网络工具使用SF-36v2。CYSF患者通过与胱氨酸尿症相关的网站、两个患者倡导组织以及一个活跃的腔内泌尿外科诊所招募。NCSF患者从同一诊所和通过电子邮件招募。有可评分数据的调查总数:214名CYSF患者和81名NCSF患者。参与者包括128名男性和161名女性。CYSF组明显更年轻(39岁对54岁),患肾结石的时间更长(255个月对136个月)。在过去一年中,CYSF患者的结石发作次数明显多于NCSF患者(CYSF组N = 108,NCSF组N = 20)。过去一年中更频繁的结石发作和精神合并症最常预示着个体HRQoL领域的得分更差。然而,胱氨酸结石成分仅是角色情感得分更差的一个重要预测因素。所有SF-36领域中更好的得分与自上次肾结石事件以来更长的时间相关。尽管肾结石通常是短暂的,但无论结石成分如何,肾结石形成者的HRQoL都比美国标准人群更差,美国标准人群的标准得分为50分,例如总体健康(41.2±12.8)、身体疼痛(46.5±11.8)和心理健康(45.1±12.6)。与NCSF相比,CYSF是更频繁且更严重的结石形成者,因此对CYSF患者的HRQoL有更大的直接影响。应该确定从业者是否正确使用了胱氨酸尿症的预防策略,以及哪些策略最有效。

相似文献

1
Health-related quality of life (HRQoL) in cystine compared with non-cystine stone formers.胱氨酸结石患者与非胱氨酸结石患者的健康相关生活质量(HRQoL)比较。
Urolithiasis. 2014 Feb;42(1):53-60. doi: 10.1007/s00240-013-0621-4. Epub 2013 Nov 20.
2
Cystine Stone Formers Have Impaired Health-Related Quality of Life Compared with Noncystine Stone Formers: A Case-Referent Study Piloting the Wisconsin Stone Quality of Life Questionnaire Among Patients with Cystine Stones.与非胱氨酸结石患者相比,胱氨酸结石患者的健康相关生活质量受损:一项在胱氨酸结石患者中试用威斯康星结石生活质量问卷的病例对照研究。
J Endourol. 2017 Apr;31(S1):S48-S53. doi: 10.1089/end.2016.0564. Epub 2016 Nov 8.
3
Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis.胱氨酸尿症与其他形式肾结石相比,肾功能降低及治疗的益处。
BJU Int. 2006 Jun;97(6):1285-90. doi: 10.1111/j.1464-410X.2006.06169.x.
4
Clinical Outcomes for Cystinuria Patients with Unilateral Versus Bilateral Cystine Stone Disease.单侧与双侧胱氨酸结石病的胱氨酸尿症患者的临床结局
J Endourol. 2018 Feb;32(2):148-153. doi: 10.1089/end.2017.0335. Epub 2018 Jan 3.
5
Assessment of health-related quality of life in patients with cystinuria on tiopronin therapy.评估巯丁二酸治疗胱氨酸尿症患者的健康相关生活质量。
Urolithiasis. 2020 Aug;48(4):313-320. doi: 10.1007/s00240-019-01174-6. Epub 2019 Dec 13.
6
Staghorn cystine stone in a 72-year-old recurrent calcium stone former.一名72岁复发性钙结石患者的鹿角形胱氨酸结石。
Clin Nephrol. 2012 Jul;78(1):76-80. doi: 10.5414/cn107046.
7
Cystine crystalluria and urinary saturation in cystine and non-cystine stone formers.胱氨酸结石形成者和非胱氨酸结石形成者中的胱氨酸结晶尿症及尿液饱和度
Urol Res. 1981;9(4):163-8. doi: 10.1007/BF00264821.
8
Disrupting Crystal Growth through Molecular Recognition: Designer Therapies for Kidney Stone Prevention.通过分子识别破坏晶体生长:用于预防肾结石的设计疗法。
Acc Chem Res. 2022 Feb 15;55(4):516-525. doi: 10.1021/acs.accounts.1c00631. Epub 2022 Jan 28.
9
Cystine stones: a single tertiary center experience.胱氨酸结石:一家三级中心的经验
J Endourol. 2015 Mar;29(3):362-6. doi: 10.1089/end.2014.0478. Epub 2014 Oct 9.
10
Conversion from Cystine to Noncystine Stones: Incidence and Associated Factors.胱氨酸结石转化为非胱氨酸结石:发生率及相关因素。
J Urol. 2018 Dec;200(6):1285-1289. doi: 10.1016/j.juro.2018.07.047. Epub 2018 Jul 27.

引用本文的文献

1
The antioxidant l-Ergothioneine prevents cystine lithiasis in the Slc7a9 mouse model of cystinuria.抗氧化剂 L-ergothioneine 可预防胱氨酸结石症 Slc7a9 小鼠模型中的胱氨酸结石形成。
Redox Biol. 2023 Aug;64:102801. doi: 10.1016/j.redox.2023.102801. Epub 2023 Jun 26.
2
Outcomes of Paediatric Cystine Stone Management: Results of a Systematic Review.小儿胱氨酸结石管理的结局:系统评价的结果。
Curr Urol Rep. 2023 Aug;24(8):371-380. doi: 10.1007/s11934-023-01162-9. Epub 2023 Apr 20.
3
A Summary of Current Guidelines and Future Directions for Medical Management and Monitoring of Patients with Cystinuria.胱氨酸尿症患者医学管理与监测的现行指南及未来方向总结
Healthcare (Basel). 2023 Feb 24;11(5):674. doi: 10.3390/healthcare11050674.
4
Accurate 24-h urine cystine quantification for patients on cystine-binding thiol drugs.准确测定应用半胱氨酸结合巯基药物患者的 24 小时尿液胱氨酸定量。
Urolithiasis. 2022 Dec;50(6):721-727. doi: 10.1007/s00240-022-01364-9. Epub 2022 Oct 6.
5
Cystinuria: An Overview of Challenges and Surgical Management.胱氨酸尿症:挑战与外科治疗概述
Front Surg. 2022 Jun 16;9:812226. doi: 10.3389/fsurg.2022.812226. eCollection 2022.
6
Common needs in uncommon conditions: a qualitative study to explore the need for care in pediatric patients with rare diseases.常见条件下的罕见需求:一项定性研究,旨在探索罕见病儿科患者的护理需求。
Orphanet J Rare Dis. 2022 Apr 4;17(1):153. doi: 10.1186/s13023-022-02305-w.
7
What is the relationship of stress to patients' kidney stone-related quality of life?压力与患者肾结石相关的生活质量之间有什么关系?
Can Urol Assoc J. 2021 May;15(5):E256-E260. doi: 10.5489/cuaj.6652.
8
Translation and Linguistic Validation of the Korean Version of the Wisconsin Stone Quality of Life Questionnaire.威斯康星结石生活质量问卷韩文版的翻译与语言验证
Int Neurourol J. 2020 Mar;24(1):77-83. doi: 10.5213/inj.1836238.119. Epub 2020 Mar 31.
9
Assessment of health-related quality of life in patients with cystinuria on tiopronin therapy.评估巯丁二酸治疗胱氨酸尿症患者的健康相关生活质量。
Urolithiasis. 2020 Aug;48(4):313-320. doi: 10.1007/s00240-019-01174-6. Epub 2019 Dec 13.
10
Cystinuria: genetic aspects, mouse models, and a new approach to therapy.胱氨酸尿症:遗传方面、小鼠模型和一种新的治疗方法。
Urolithiasis. 2019 Feb;47(1):57-66. doi: 10.1007/s00240-018-1101-7. Epub 2018 Dec 4.

本文引用的文献

1
Development of an instrument to assess the health related quality of life of kidney stone formers.评估肾结石患者健康相关生活质量的工具的开发。
J Urol. 2013 Mar;189(3):921-30. doi: 10.1016/j.juro.2012.08.247. Epub 2012 Sep 24.
2
Health related quality of life for stone formers.结石患者的健康相关生活质量。
J Urol. 2012 Aug;188(2):436-40. doi: 10.1016/j.juro.2012.04.015. Epub 2012 Jun 14.
3
Increased risk of depressive disorder within 1 year after diagnosis with urinary calculi in Taiwan.在台湾,尿路结石诊断后 1 年内抑郁障碍发病风险增加。
Psychiatry Res. 2012 Jul 30;198(2):332-3. doi: 10.1016/j.psychres.2012.01.007. Epub 2012 Mar 13.
4
Association of depression and urolithiasis.抑郁与尿石症的相关性。
Urology. 2012 Mar;79(3):518-25. doi: 10.1016/j.urology.2011.10.007. Epub 2011 Dec 3.
5
Longitudinal evaluation of the SF-36 quality of life questionnaire in patients with kidney stones.肾结石患者SF-36生活质量问卷的纵向评估
Urol Res. 2011 Apr;39(2):141-6. doi: 10.1007/s00240-010-0313-2. Epub 2010 Oct 6.
6
Economics and cost of care of stone disease.结石病的经济学与治疗成本
Adv Chronic Kidney Dis. 2009 Jan;16(1):5-10. doi: 10.1053/j.ackd.2008.10.002.
7
Determinants of quality of life for patients with kidney stones.肾结石患者生活质量的决定因素。
J Urol. 2008 Jun;179(6):2238-43; discussion 2243. doi: 10.1016/j.juro.2008.01.116. Epub 2008 Apr 18.
8
Cystinuria.胱氨酸尿症
Semin Nephrol. 2008 Mar;28(2):181-91. doi: 10.1016/j.semnephrol.2008.01.011.
9
Health related quality of life differs between male and female stone formers.男性和女性结石患者的健康相关生活质量存在差异。
J Urol. 2007 Dec;178(6):2435-40; discussion 2440. doi: 10.1016/j.juro.2007.08.009. Epub 2007 Oct 15.
10
Reconsideration of the 1988 NIH Consensus Statement on Prevention and Treatment of Kidney Stones: Are the Recommendations Out of Date?对1988年美国国立卫生研究院关于肾结石预防与治疗的共识声明的重新审视:这些建议是否过时?
Rev Urol. 2002 Spring;4(2):53-60.